Dubai, UAE- 25 June 2024- Dubai Health Authority (DHA) has announced a new set of standards for regulating the provision of oncology services in health facilities providing the services in Dubai; in collaboration with the Emirates Oncology Society.
- During the workshop held at Raffles Hotel- Dubai, in collaboration with Professor Humaid Al Shamsi, Chairman of the Oncology Society at the Emirates Medical Association, DHA reviewed the new standards for Oncology services. The document has been developed in accordance with UAE legislations and the best international practices in the field. The workshop was attended by several strategic partners and representatives from healthcare facilities offering oncological services in Dubai.
- Dr. Hanan Obaid, Director of Health Policies and Standards department at the Dubai Health Authority, stated that the new standards were developed with a focus on patient-centered care and include a set of regulations and requirements related to medical care, patient safety , KPIs for quality and performance for measuring and monitoring the effectiveness of the oncology services in the health facilities.
The initiative comes in alignment with the goals and priorities set forth in Dubai’s Healthcare Strategy 2026; which aims to establish a pioneering healthcare system that boosts patients and their families’ confidence and contributes to making Dubai one of the leading destinations for healthcare with the best patients’ outcomes.
This is one of DHA’s ongoing efforts to develop the healthcare sector in Dubai, ensuring the provision of specialised, high-quality treatment services that further improves patient safety.
During the workshop held at Raffles Hotel- Dubai, in collaboration with Professor Humaid Al Shamsi, Chairman of the Oncology Society at the Emirates Medical Association, DHA reviewed the new standards for Oncology services. The document has been developed in accordance with UAE legislations and the best international practices in the field. The workshop was attended by several strategic partners and representatives from healthcare facilities offering oncological services in Dubai.
Dr. Marwan Al Mulla, CEO of the Health Regulation Sector at DHA, stressed that oncology services remain one of the main challenges for health authorities worldwide. Accordingly, DHA has taken the initiative to develop the new standards aiming to build an effective system and provide advanced services in this field. The new standards also reflect DHA’s commitment to achieving the best outcomes for patients by offering high-quality of diagnostic and therapeutic services and improve patient experience in their journey to recovery. Regulations will also contribute to enhancing efficiency, sustainability, and accessibility of healthcare within a patient-centered system.
Did DHA conduct 615 inspection visits during the first quarter of this year?
Dr. Hanan Obaid, Director of Health Policies and Standards department at the Dubai Health Authority, stated that the new standards were developed with a focus on patient-centered care and include a set of regulations and requirements related to medical care, patient safety , KPIs for quality and performance for measuring and monitoring the effectiveness of the oncology services in the health facilities.
Also Read: Bayer and Aignostics to collaborate on next-generation precision oncology
Dr. Hanan also added that these standards are evidence-based and align with the best practices to improve the therapeutic experience for patients and elevate the level and quality of services provided to them.
Additionally, Dr. Khulood Al Sayegh, Head of the Standards and Guidelines Section at DHA, added that the workshop highlighted several key points related to the implementation of the new standards for providing oncology services as required by DHA. The workshop also stressed on the importance of continuously developing and updating these regulations to keep pace with the fast progresses in the field of oncology ; focusing on precise diagnostic services, enhancing the integration of multispecialty care, and prioritising patient outcomes and quality of life.
